Skip to main content

Table 3 Percentages of incident hemodialysis and peritoneal dialysis patients with prescriptions for specific blood pressure medications at 6 months by cardiovascular risk factor or disease, 2003-2008

From: Patterns in blood pressure medication use in US incident dialysis patients over the first 6 months

 

Hemodialysis, n = 12,159

Peritoneal dialysis, n = 913

  

CHF

CVD

Diabetes

 

CHF

CVD

Diabetes

Medication

All

Yes

No

Yes

No

Yes

No

All

Yes

No

Yes

No

Yes

No

None

12

10

13

11

13

10

15

10

7

10

7

11

5

14

Beta-blocker

              

  Any

59

65

55

64

53

62

54

55

69

51

67

48

61

48

  Alpha-beta

19

26

13

22

15

20

16

13

25

10

17

11

16

10

  Beta not alpha

41

39

42

43

38

42

38

42

44

41

51

37

45

38

RAS *

              

  Any

45

45

45

44

46

49

39

52

54

51

55

50

57

46

  ACEI

32

32

31

31

32

34

27

33

36

32

34

32

35

30

  ARB

17

16

17

16

18

19

14

23

22

23

25

22

26

19

CCB

              

  Any

49

44

52

45

52

49

47

50

43

51

48

51

54

44

  DHP

40

36

43

37

43

41

39

40

35

41

38

41

42

37

  Non-DHP

9

8

9

8

9

9

8

10

8

10

10

10

13

7

Diuretic

              

  Any

28

31

24

28

26

31

21

41

55

37

52

35

50

32

  Loop

26

30

22

26

24

29

19

38

53

34

50

33

47

29

  Thiazide

5

5

4

4

5

5

3

9

13

8

13

6

12

5

Alpha blocker

7

6

7

7

6

7

7

10

8

10

12

9

11

7

Central alpha 2 agonist

19

18

20

17

21

20

18

15

14

16

14

16

16

14

Hydralazine

8

11

6

9

7

9

7

4

9

3

5

4

6

3

Minoxidil

4

3

4

3

5

4

5

2

2

3

1

3

2

2

  1. Note: Values are percentages except for the n row, which represents number of individuals.
  2. ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker; CCB, calcium channel blocker; DHP, dihydropyridine; RAS, renin angiotensin system agent.
  3. *Renin-inhibitors comprised < 1% of RAS agents from 2003–2008.
  4. Potassium-sparing diuretics comprised < 1% of diuretic agents from 2003–2008.